GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, GRIK5, GRM5, HSD17B2, IGF1R, INSR, MAOB, MMP2, MMP9, PIK3CA, PPARA, PPARD, PTGS2, RORC, SRC, TEK, TYR |
11.831 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA12, CA2, CA7, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOB, MET, MIF, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
11.2437 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FUT7, GLO1, HSPA1A, MIF, PDE5A, PIK3CA, PIM1, PPARA, PPARD, PTGS1, PTGS2, TYR, XDH |
11.221 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.1865 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MMP2, PIK3CA, PPARA, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
11.1119 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, MIF, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2 |
11.1119 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.445 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
10.445 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
10.445 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GLO1, GRIK5, HCAR2, HSPA1A, IGF1R, KDR, MIF, MMP9, PIK3CA, PIK3CB, PIM1, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, XDH |
9.75648 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.60138 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, APP, AXL, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, FLT3, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.57696 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.37048 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, APP, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MMP2, MMP9, PIK3CA, PPARA, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
9.34096 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, APP, AURKB, AXL, CA2, CA7, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
9.22868 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, CDC25B, CSNK2A1, CYP1B1, EGFR, ESR1, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIM1, PPARD, PTGS1, PTGS2, SMAD3, SRC, TEK, XDH |
8.166 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AXL, CYP1B1, EGFR, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SRC, TEK, XDH |
8.16365 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
8.09394 |
[BP] GO:0007215 |
None
|
APP, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.04931 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
8.04931 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, HSD17B2, MAOB, PPARD, PTGS2, RORC, SRC, TYR |
8.0155 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SRC, TEK, XDH |
7.94346 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
7.91198 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.77325 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, CNR1, CNR2, EGFR, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.77325 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.68693 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
7.65105 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, APP, AXL, CSNK2A1, CYP1B1, EGFR, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.60913 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, FABP3, FABP4, FUT7, MET, MIF, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2 |
7.60913 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MET, MIF, MMP9, PIK3CA, PIM1, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK |
7.60092 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
7.48795 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, GRM5, IGF1R, INSR, MAOB, MMP2, PPARA, PTGS2, SMAD3, SRC, TEK |
7.4794 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, APEX1, APP, AURKB, AXL, CA2, CA7, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, XDH |
7.33924 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FLT3, MAOB, PTGS2, RORC, SRC, TEK, TYR |
7.2316 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, EGFR, GRM1, GRM3, GRM5, GRM8, PTGS2 |
7.21778 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, APP, AXL, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, HSPA1A, IGF1R, INSR, KDR, MMP2, MMP9, PIK3CA, PPARD, PTGS2, RORC, SMAD3, SRC |
7.10542 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.09495 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP3, FABP4, FLT3, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
7.04121 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIK3CA, PIM1, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.96524 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA6, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP3, FABP4, FLT3, GRIK5, GRM1, GRM5, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MIF, MMP12, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR |
6.94271 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, MIF, PPARA, PPARD, PTGS1, PTGS2 |
6.92076 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP2, MMP9, NUAK1, PIK3CA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TOP2A |
6.86506 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, APP, AXL, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1B1, EGFR, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK |
6.86411 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1, HSD17B2, PPARD |
6.7341 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, MAOB, NQO2, PPARD, PTGS1, PTGS2, TYR, XDH |
6.6615 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, APP, AXL, CYP1A1, CYP1B1, EGFR, ESR1, FABP4, FLT3, GRIK5, GRM5, IGF1R, INSR, KDR, MMP2, PIK3CA, PPARD, PTGS2, RORC, SMAD3, SRC |
6.6615 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, APP, AXL, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MAOB, MMP9, PTGS2, SRC |
6.57417 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, APEX1, APP, AXL, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, FLT3, GPR35, GRIK5, GRM1, GRM5, INSR, MET, PIK3CA, PIK3CB, SMAD3, SRC |
6.50477 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, MIF, PTGS1, PTGS2 |
6.48236 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.44955 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AXL, CNR1, CSNK2A1, CYP1B1, EGFR, FABP4, FLT3, GPR35, GRM1, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.36082 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, FABP3, FLT3, INSR, MAOB, PPARA, PTGS2, SRC, TEK |
6.29469 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, ESR1, GRIK5, GRM5, IGF1R, INSR, MMP2, MMP9, PIK3CA, PPARD, PTGS2, RORC, SRC |
6.28248 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP2, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
6.27168 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APP, AXL, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, GRM1, GRM5, GRM8, HSD17B2, IGF1R, INSR, MET, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
6.24217 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARD, SLC1A1 |
6.2376 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
6.19331 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
6.14804 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, APP, CDC25B, EGFR, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.02974 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, APP, CDC25B, EGFR, FABP3, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
6.02974 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.99707 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, CA1, CSNK2A1, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
5.85257 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALPL, APEX1, APP, AURKB, AXL, CA2, CA9, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, HSD17B2, INSR, KDR, MAOB, MET, MIF, MMP2, MMP9, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TOP2A, TYR |
5.83258 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
5.76828 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.64398 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, PIM1, SRC, TEK |
5.64398 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, CA12, CA2, CA7, CNR1, EGFR, ESR1, FABP3, FABP4, GPR35, GRIK5, GRM1, GRM5, INSR, MET, PIK3CA, PIK3CB, SMAD3 |
5.64398 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.63402 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HSPA1A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
5.60543 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.58944 |
[BP] GO:0032787 |
None
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, MIF, PPARA, PPARD, PTGS1, PTGS2 |
5.58944 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARD, PTGS2, PTPN1, SRC, TEK, XDH |
5.52873 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, CDC25B, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, GRM1, GRM3, GRM5, HSPA1A, IGF1R, INSR, MET, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
5.50813 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
5.50767 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, MIF, PDE5A, PIK3CB, PTPN1, SRC |
5.4168 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.3975 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CA7, CNR1, CYP19A1, EGFR, GPR35, GRIK5, GRM5, HCAR2, HSPA1A, INSR, MAOB, MIF, MMP12, MMP9, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC |
5.38961 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, APP, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.37863 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.33073 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, HSPA1A, MMP12, MMP2, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK |
5.32418 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
5.32418 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
5.31272 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, CYP19A1, CYP1B1, EGFR, IGF1R, INSR, KDR, MET, MIF, MMP9, PPARD, PTGS2, SMAD3, SRC, TEK |
5.31008 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, APP, EGFR, FLT3, GRM1, INSR, KDR, MIF, PDE5A, PIK3CB, PTPN1, SRC, TEK, XDH |
5.30173 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
5.22797 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
5.21858 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, SRC, TEK, XDH |
5.20002 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, IGF1R, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
5.19468 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, APP, AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARD, PTGS2, PTPN1, SRC, TEK, XDH |
5.19468 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.1753 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, APP, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, KDR, MIF, PDE5A, PIK3CB, PTPN1, SRC, TEK, XDH |
5.127 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, CNR1, CNR2, EGFR, FABP3, FLT3, GRM5, IGF1R, INSR, MMP2, PPARA, PTGS2, SRC, TEK, TYR |
5.11215 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DUSP3, ESR1, FABP4, GPR35, GRM3, IGF1R, MET, MMP9, PIM1, PPARA, PTGS2, PTPN1, SRC |
5.03403 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARD, SLC1A1 |
5.00325 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.97734 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ESR1, FLT3, HSD17B2, INSR, KDR, PIK3CA, PPARA, PPARD, SMAD3, SRC, TEK, TYR |
4.92735 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, GLO1, GPR35, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.89343 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, PPARA, PPARD, PTGS2, SMAD3, TEK |
4.89343 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.84029 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.80477 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.7909 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK |
4.71776 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, IGF1R, INSR, KDR, MIF, MMP12, MMP2, MMP9, PIM1, PPARD, PTGS2, TEK |
4.69233 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.68913 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, FABP4, KDR, MET, MIF, MMP12, PPARA, PPARD, PTGS2, SMAD3, TEK |
4.66249 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC, TEK |
4.64101 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, APP, CDC25B, DUSP3, EGFR, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.63504 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, MIF, PDE5A, PIK3CB, PTPN1, SRC |
4.61859 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CNR1, CYP19A1, CYP1A1, CYP1B1, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2, PPARD |
4.54283 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PTGS1, PTGS2, SRC |
4.53854 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SRC |
4.50032 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.49947 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2 |
4.49947 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, CA1, CA2, CNR1, CNR2, CSNK2A1, CYP1B1, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MIF, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTPN1, RORC, SMAD3, SRC, TEK |
4.48994 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, GRM5, IGF1R, INSR, PPARA, PTGS2, SRC, TEK |
4.4808 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, APP, AURKB, CDC25B, EGFR, ESR1, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.4808 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, ESR1, FLT3, PTGS2, RORC, SRC |
4.46223 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, PPARD, PTGS2, SRC |
4.46123 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK |
4.4604 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, INSR, MET, PIK3CA, PIK3CB, SRC, TEK, XDH |
4.45457 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.40523 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, FUT7, HSPA1A, MAOB, MMP1, MMP12, MMP2, MMP9, PDE5A, PIK3CB, PPARD, SRC, XDH |
4.4037 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, APP, AURKB, AXL, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DUSP3, EGFR, ESR1, FABP4, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.39899 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, APP, AURKB, AXL, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FLT3, GPR35, GRM1, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.36775 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, FABP3, FLT3, HCAR2, PPARA, PTGS2, RORC, SRC, TEK |
4.3394 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
4.32538 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.32538 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, PPARD, PTGS2, SRC |
4.22678 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, APP, CDC25B, EGFR, FLT3, GRM1, GRM5, INSR, KDR, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SRC, TEK, XDH |
4.2209 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, PTGS1, PTGS2, TYR |
4.20683 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, HSD17B2, MIF, PIK3CA, PIK3CB, PPARD, PTGS1, PTGS2 |
4.20119 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, NQO2, PTGS1, RORC |
4.18112 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, CYP1A1, EGFR, ESR1, FLT3, MET, MIF, PIK3CB, PIM1, PPARD, SRC, TEK, TYR |
4.17355 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, PPARA, PPARD, SMAD3, TEK |
4.16308 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DUSP3, EGFR, ESR1, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
4.13976 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, MMP12, PPARA, PPARD, SMAD3, TEK |
4.12094 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, CA2, CA7, CNR1, EGFR, HCAR2, KDR, MIF, PIK3CB, PTGS2, SRC |
4.08671 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FABP3, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
4.08495 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, CA2, CYP1A1, EGFR, GRM1, HSPA1A, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK, TYR |
4.03952 |
[BP] GO:0042391 |
None
|
ADORA1, APP, CNR1, CNR2, GPR35, GRIA2, GRIA4, GRIK5, GRM5, KDR, SRC |
3.9703 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, APP, AURKB, CDC25B, CSNK2A1, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIK3CB, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.96302 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, CNR1, CNR2, CYP1A1, CYP1B1, KDR, MAOB, SRC |
3.95399 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.91935 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1, HSD17B2 |
3.88715 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, CNR1, CNR2, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, GRM3, GRM8, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
3.86738 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, FLT3, GRM1, IGF1R, INSR, MIF, PDE5A, PIK3CB, PTPN1, SRC |
3.85242 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, APP, AURKB, CDC25B, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, MIF, PDE5A, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, XDH |
3.84802 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, EGFR, GRIK5, INSR, MAOB, PTGS2, SLC1A1, SMAD3 |
3.84802 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, PPARD, PTGS2, TYR |
3.84548 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
3.79906 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AXL, CA2, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, EGFR, HSPA1A, MIF, MMP2, MMP9, NUAK1, PIK3CA, PIK3CB, PPARA, PPARD, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A |
3.7827 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
3.77408 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.76097 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, SRC |
3.76002 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, PTGS1, PTGS2, TYR |
3.71129 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
3.70657 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.70657 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CNR1, CSNK2A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.68182 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, CDC25B, EGFR, ESR1, FLT3, GRM1, GRM5, HSPA1A, INSR, MET, MIF, MMP9, PDE5A, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC, TEK, XDH |
3.67618 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, FLT3, GRM1, INSR, MIF, PDE5A, PIK3CB, PTPN1, SRC |
3.65016 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, CA9, CNR1, CNR2, CYP1A1, CYP1B1, EGFR, FABP3, KDR, MAOB, PTGS2, SRC |
3.64771 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, MIF, PIM1, PPARA, PPARD, PTGS1, PTGS2, TYR |
3.63114 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
3.61293 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, APP, AXL, CA2, CNR1, CYP1B1, EGFR, ESR1, GPR35, GRM1, HCAR2, HSPA1A, INSR, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIK3CA, PIM1, PPARD, PTGS2, SLC1A1, SMAD3, SRC, TEK, XDH |
3.59419 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.58979 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.58979 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.52785 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1, MAOB |
3.52785 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
3.52401 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, APP, AXL, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FLT3, HSD17B2, INSR, KDR, MAOB, MMP9, PIK3CA, PIM1, PPARA, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TYR |
3.51333 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
3.48528 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, INSR, MIF, SRC |
3.46494 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, CYP1A1, MMP2, PPARA, PPARD, PTGS2, SMAD3, SRC, TEK |
3.44408 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, APP, AXL, CA2, CNR1, CNR2, CYP19A1, DUSP3, ESR1, HCAR2, HSPA1A, MIF, MMP12, MMP2, PDE5A, PIK3CA, PIK3CB, PTPN1, SMAD3, SRC |
3.43415 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
APP, AXL, CA2, CNR1, CYP1B1, EGFR, HCAR2, HSPA1A, KDR, MET, MIF, MMP12, MMP9, PDE5A, PIM1, PTGS2, SLC1A1, SMAD3, SRC, TEK |
3.41035 |
[BP] GO:0050665 |
hydrogen peroxide biosynthetic process
|
CYP1A1, CYP1A2, MAOB |
3.40937 |
[BP] GO:0035235 |
None
|
APP, GRIA2, GRIA4, GRIK5 |
3.40256 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
3.38306 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.35812 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, EGFR, FUT7, KDR, MET, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.3439 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, EGFR, HCAR2, PIK3CB, PTGS2 |
3.3339 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, CDC25B, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.33195 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, CNR2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
3.33172 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, EGFR, ESR1, FLT3, GRM5, IGF1R, INSR, MMP2, PTGS2, SMAD3, SRC |
3.32104 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, CNR2, DUSP3, EGFR, ESR1, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PTGS2, PTPN1, SMAD3, SRC, XDH |
3.31865 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, CNR1, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PIK3CA, PIK3CB, PPARA, PTPN1, SMAD3 |
3.29332 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, SRC, TEK |
3.27916 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, GRM5, MIF, PTPN1, SRC |
3.27916 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, PPARD |
3.26871 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, EGFR, IGF1R, INSR, KDR, MET, MMP9, PTGS2, SMAD3, SRC, TEK |
3.26871 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, PTGS2, SRC |
3.26871 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CNR1, EGFR, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SMAD3, SRC |
3.22619 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR, MAOB |
3.1863 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CNR1, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.17492 |
[BP] GO:0010038 |
response to metal ion
|
APP, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MAOB, MMP9, PTGS2 |
3.17413 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.13326 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.13326 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.12887 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, CA2, CYP19A1, EGFR, HCAR2, INSR, MIF, MMP12, PPARD, PTGS2, SMAD3, SRC |
3.05473 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
DUSP3, ESR1, HSPA1A, IGF1R, MET, MIF, MMP9, PTGS2, PTPN1, SRC, XDH |
3.05406 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, CYP1A1, EGFR, PPARA, PPARD, SMAD3 |
3.05374 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, CDC25B, CNR1, CYP19A1, CYP1A1, EGFR, ESR1, HSD17B2, INSR, MMP2, MMP9, PPARD, PTGS2, SRC, TOP2A |
3.04632 |
[BP] GO:0019371 |
None
|
CBR1, PTGS1, PTGS2 |
3.00669 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MIF, MMP12, PPARD, SRC |
3.00325 |
[BP] GO:0007187 |
None
|
ADORA1, CNR1, CNR2, GRM1, GRM3, GRM5, GRM8 |
2.99844 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR, PTGS2 |
2.99844 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, GRM5, IGF1R, INSR, MMP2, PTGS2, SRC |
2.99802 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, EGFR, HSPA1A, MAOB |
2.98394 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.97769 |
[BP] GO:0048010 |
vascular endothelial growth factor receptor signaling pathway
|
AXL, KDR, PIK3CA, PIK3CB, SRC |
2.96982 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, PPARA, PTGS2, SRC, TEK |
2.96776 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, CNR1, CNR2, CYP1B1, EGFR, GRM1, GRM5, GRM8, INSR, PDE5A, PIK3CA, PPARD, PTGS2, SRC, TEK, TYR |
2.93743 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, EGFR, PPARD |
2.93433 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PTGS2, SRC, TEK |
2.93433 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, CNR1, EGFR, HCAR2, MET, PIK3CA, PPARA, SMAD3 |
2.92782 |
[BP] GO:0045759 |
None
|
CNR1, CNR2, GPR35 |
2.90809 |
[BP] GO:0050900 |
leukocyte migration
|
CNR2, FUT7, MIF, MMP1, MMP9, PIK3CA, PIK3CB, SRC, TEK |
2.88516 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PPARD, PTGS2 |
2.88208 |
[BP] GO:0007584 |
response to nutrient
|
ALPL, CNR1, CYP1A1, EGFR, PPARD, PTGS2, TYR |
2.87471 |
[BP] GO:0007193 |
None
|
ADORA1, GRM1, GRM3, GRM5, GRM8 |
2.87431 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9, PTGS2 |
2.87431 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX5, MIF, PTGS1, PTGS2 |
2.86791 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4, PPARD |
2.86154 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
2.85512 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
2.83627 |
[BP] GO:0007566 |
embryo implantation
|
MMP2, MMP9, PPARD, PTGS2 |
2.83194 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, APEX1, APP, AURKB, CA9, CDC25B, CSNK2A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GRM1, GRM3, GRM5, GRM8, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP12, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
2.82892 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
APP, DUSP3, EGFR, KDR, MIF, PTPN1, SRC, TEK |
2.82493 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82369 |
[BP] GO:0001516 |
None
|
MIF, PTGS1, PTGS2 |
2.82369 |
[BP] GO:0046457 |
None
|
MIF, PTGS1, PTGS2 |
2.82369 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, CNR1, CNR2, ESR1, GPR35, GRM1, GRM3, GRM5, GRM8, HCAR2, INSR, PIK3CA, PIK3CB, SRC |
2.80291 |
[BP] GO:0050801 |
ion homeostasis
|
APP, CA12, CA2, CA7, EGFR, ESR1, FABP3, GPR35, GRM1, GRM5, PIK3CB, SMAD3 |
2.78407 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, MIF, PPARA, PPARD, SMAD3, TEK |
2.77921 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, FABP4, KDR, MET, MIF, PTGS2, SMAD3 |
2.77921 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CSNK2A1, CYP1A1, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, PTGS2, SMAD3, SRC, TOP2A |
2.75192 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, FABP3, GRIA2, GRIA4, GRIK5, PPARA, PPARD, SLC1A1 |
2.75192 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, PTGS2, SRC |
2.75192 |
[BP] GO:2000106 |
regulation of leukocyte apoptotic process
|
AURKB, AXL, HCAR2, MIF, PIK3CB |
2.74862 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5, MIF |
2.74862 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, CDC25B, CSNK2A1, CYP1A1, CYP1A2, DUSP3, EGFR, ESR1, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIM1, PPARA, PPARD, PTGS2, PTPN1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.74588 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.73957 |
[BP] GO:0048511 |
rhythmic process
|
AXL, CSNK2A1, EGFR, ESR1, PPARA, RORC, SRC, TOP2A |
2.73875 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.73006 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.73006 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CNR1, CYP19A1, EGFR, GRIK5, HCAR2, MAOB, MIF, MMP12, PPARD, SRC |
2.72411 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, GRM5, IGF1R, INSR, SRC |
2.71542 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.70599 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, CNR1, GPR35, MAOB, MMP9, PTGS2 |
2.69974 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, SRC, TEK |
2.65642 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MIF, MMP12, PPARD, SRC |
2.65642 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DUSP3, INSR |
2.65523 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, EGFR, HCAR2, MIF, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.64913 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, APP, CDC25B, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, FLT3, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MIF, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PTGS2, PTPN1, SMAD3, SRC, TEK, XDH |
2.61483 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.59762 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, CA2, EGFR, FLT3, MAOB, PTGS2, SRC |
2.59479 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PTGS2, SMAD3, XDH |
2.58817 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.5873 |
[BP] GO:0008217 |
None
|
ADORA1, CNR1, PPARA, PTGS1, PTGS2, SMAD3 |
2.58699 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, CDC25B, CYP19A1, EGFR, ESR1, HSD17B2, INSR, PPARD, PTGS2, SRC |
2.57029 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, EGFR, FLT3, FUT7, HSPA1A, MIF, MMP9, PIK3CA, PIK3CB, RORC, SMAD3, SRC |
2.54708 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
CNR1, CYP1B1, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.52087 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, CA2, CA7, CNR1, GPR35, GRM5, MAOB, MIF, MMP9, PTGS2 |
2.51575 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, EGFR, FLT3, MAOB, PTGS2, SRC |
2.49903 |
[BP] GO:0003018 |
None
|
ADORA1, EGFR, PPARD, PTGS2, SRC, TEK |
2.49903 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
CNR1, CYP1B1, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.48764 |
[BP] GO:0007188 |
None
|
ADORA1, CNR1, GRM1, GRM3, GRM5, GRM8 |
2.48607 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, AXL, CNR1, CNR2, CYP19A1, DUSP3, MIF, MMP12, PDE5A |
2.48201 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
2.48078 |
[BP] GO:0006928 |
movement of cell or subcellular component
|
APP, AXL, CNR2, CYP1B1, EGFR, FUT7, KDR, MIF, MMP1, MMP12, MMP9, PIK3CA, PIK3CB, PPARD, PTGS2, SRC, TEK |
2.47768 |
[BP] GO:0032147 |
activation of protein kinase activity
|
ADORA1, EGFR, GRM1, INSR, PIK3CA, PIK3CB, PTPN1, SRC |
2.47748 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.47654 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.47654 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
HSPA1A, MIF, MMP9, PTGS2, PTPN1, SRC |
2.46942 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CNR1, CYP19A1, EGFR, GRIK5, HCAR2, MAOB, MIF, MMP12, PPARD, SRC |
2.46847 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, PPARD, TEK |
2.46318 |
[BP] GO:0016101 |
None
|
AKR1B10, CYP1A1, CYP1B1, EGFR, PPARD |
2.46318 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, CBR1, CDC25B, CYP1A1, EGFR, ESR1, FABP4, FLT3, FUT7, GLO1, KDR, MET, MIF, MMP2, MMP9, PPARD, PTGS2, RORC, SMAD3, SRC, TEK, TOP2A |
2.45098 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, EGFR, HCAR2, MIF, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.44439 |
[BP] GO:0050714 |
None
|
ACHE, EGFR, HCAR2, MIF, MMP12, PPARD, SRC |
2.4384 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1B1, MAOB, PPARD, TYR |
2.4384 |
[BP] GO:0033138 |
positive regulation of peptidyl-serine phosphorylation
|
APP, EGFR, MIF, PIK3CA, PTGS2 |
2.42702 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, EGFR, GPR35, GRM1, HCAR2, PDE5A, PTGS2, SLC1A1, SMAD3 |
2.42275 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGS2, SRC |
2.42275 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, MAOB, NQO2, XDH |
2.42275 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APEX1, APP, AURKB, CNR1, CSNK2A1, DUSP3, ESR1, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PIK3CA, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
2.42083 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39777 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39777 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39777 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.39777 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.39691 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.39691 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
CYP1A1, CYP1A2, CYP1B1, EGFR, MAOB |
2.38096 |
[BP] GO:0048732 |
gland development
|
CSNK2A1, CYP19A1, EGFR, INSR, PIK3CA, SMAD3, TYR |
2.37657 |
[BP] GO:0019233 |
None
|
CNR1, CNR2, GRM1, PTGS2 |
2.3678 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
KDR, PIK3CB, SMAD3, SRC, TEK |
2.36434 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, CA12, CA2, CA7, EGFR, ESR1, GPR35, GRM1, GRM5, PIK3CB, SMAD3 |
2.354 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.34133 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.34133 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
CYP1B1, EGFR, INSR, PTGS2, SMAD3, XDH |
2.34133 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, CNR1, CYP1A1, EGFR, PPARD, PTGS2, SRC, TYR |
2.32337 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PTGS2, PTPN1, XDH |
2.318 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, AXL, CNR2, MIF, PIK3CA, PIK3CB, PTGS1, PTGS2 |
2.30379 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9, PTGS2 |
2.30379 |
[BP] GO:0055082 |
cellular chemical homeostasis
|
APP, CA2, CA7, ESR1, GPR35, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, SMAD3 |
2.29781 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, GRM5, MIF, PTPN1, SRC |
2.29222 |
[BP] GO:0071498 |
cellular response to fluid shear stress
|
CA2, PTGS2, SRC |
2.2867 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, SRC |
2.28051 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, PIM1, PPARA, PPARD, RORC, SRC |
2.2693 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.26423 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, PTGS2, SMAD3 |
2.26423 |
[BP] GO:0010942 |
positive regulation of cell death
|
CNR1, CYP1B1, GRIK5, HCAR2, MMP9, PIK3CB, PTGS2, SMAD3, SRC, TOP2A, XDH |
2.2614 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
APP, AURKB, AXL, CNR1, ESR1, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, SMAD3, SRC, TEK |
2.2614 |
[BP] GO:0051223 |
None
|
ACHE, APP, CNR1, EGFR, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SMAD3, SRC |
2.25256 |
[BP] GO:0001525 |
angiogenesis
|
CYP1B1, KDR, MMP2, PIK3CA, PIK3CB, PTGS2, TEK |
2.25047 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, MAOB, SRC |
2.2431 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.2431 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.2431 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.2431 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.2431 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2431 |
[BP] GO:0019725 |
cellular homeostasis
|
APEX1, APP, CA2, CA7, ESR1, GPR35, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, SMAD3 |
2.24281 |
[BP] GO:0030155 |
regulation of cell adhesion
|
CYP1B1, DUSP3, KDR, NUAK1, PDE5A, PIK3CA, PIK3CB, PPARA, SMAD3, SRC, TEK |
2.22965 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CNR1, EGFR, HCAR2, MIF, MMP12, PPARD, SRC |
2.20684 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA12, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, XDH |
2.19756 |
[BP] GO:0001503 |
ossification
|
ALPL, EGFR, MMP2, MMP9, TEK |
2.19617 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.195 |
[BP] GO:1903532 |
None
|
ACHE, CYP19A1, EGFR, HCAR2, MIF, MMP12, PPARD, SRC |
2.18155 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.17917 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.17804 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD17B1, HSD17B2 |
2.17804 |
[BP] GO:0009888 |
tissue development
|
ALPL, CYP1B1, INSR, KDR, PIK3CA, PPARA, PPARD, PTGS2, RORC, SMAD3 |
2.17804 |
[BP] GO:0043207 |
response to external biotic stimulus
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.14789 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.14789 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CNR1, EGFR, GRM5, INSR, PTGS2 |
2.11973 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.11037 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, PTGS2 |
2.10855 |
[BP] GO:0045932 |
None
|
ADORA1, PDE5A, PTGS2 |
2.10304 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.08543 |
[BP] GO:0070201 |
None
|
ACHE, APP, CNR1, EGFR, HCAR2, MIF, MMP12, PPARD, PTGS2, PTPN1, SMAD3, SRC |
2.08195 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, CYP1B1, FABP3, HSPA1A, PDE5A, PPARD, PTGS2, SMAD3, XDH |
2.07187 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, PTGS2, SRC, TEK |
2.07167 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, PPARD, TEK |
2.06475 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.06229 |
[BP] GO:0006693 |
None
|
MIF, PTGS1, PTGS2 |
2.06229 |
[BP] GO:0006692 |
None
|
MIF, PTGS1, PTGS2 |
2.06229 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, CYP19A1, CYP1B1, MIF, PPARD |
2.05961 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, CA1, CA2, CA7, CA9, CDC25B, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
2.05608 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
APP, EGFR, KDR, MIF, SRC, TEK |
2.04789 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
CA2, CA9, EGFR, ESR1, MET, SMAD3, SRC |
2.04463 |
[BP] GO:0051172 |
None
|
APEX1, APP, AURKB, CSNK2A1, DUSP3, EGFR, ESR1, FABP4, GRM3, GRM8, HSPA1A, IGF1R, MIF, MMP12, MMP9, PPARA, PPARD, PTGS2, PTPN1, RORC, SMAD3, SRC, XDH |
2.0419 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, HSPA1A, MAOB, PDE5A, PIK3CB, PPARD, SRC, XDH |
2.0419 |
[BP] GO:1904646 |
cellular response to amyloid-beta
|
APP, GRM5, IGF1R |
2.02334 |
[BP] GO:0009607 |
response to biotic stimulus
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, MAOB, MMP12, PPARD, PTGS2, SMAD3, SRC |
2.01236 |
[BP] GO:0051128 |
regulation of cellular component organization
|
APP, AURKB, AXL, CNR1, CSNK2A1, EGFR, ESR1, GRIK5, HSPA1A, IGF1R, INSR, KDR, MET, MMP1, MMP9, PIK3CB, PPARD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.01161 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, GLO1 |
2.01161 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.01161 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CNR1, EGFR, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, MET, PTGS2, SLC1A1, SRC, TEK |
5.43447 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, EGFR, ESR1, FLT3, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTPN1, SLC1A1, SMAD3, SRC, TEK |
4.60293 |
[CC] GO:0042734 |
None
|
CNR1, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.47414 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, CNR1, CNR2, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
3.66833 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, APP, AXL, CA2, CA4, CA9, CNR1, CNR2, DUSP3, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, PTGS2, SLC1A1, SRC, TEK |
3.66833 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CNR1, CNR2, FLT3, GPR35, GRIA2, GRM1, GRM3, GRM5, GRM8, IGF1R, INSR, KDR, MET, SLC1A1, TEK |
3.37923 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FLT3, FUT7, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, INSR, KDR, MAOB, MET, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1, SRC, TEK, TYR |
3.26871 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX5, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FLT3, FUT7, GLO1, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B2, IGF1R, INSR, KDR, MAOB, MET, MMP2, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SLC1A1, SMAD3, SRC, TEK, TYR |
3.24934 |
[CC] GO:0043235 |
receptor complex
|
APP, EGFR, GRIA2, GRIA4, GRIK5, GRM1, IGF1R, INSR, SMAD3 |
3.14325 |
[CC] GO:0043005 |
None
|
ADORA1, APP, CA2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2, SRC |
2.74061 |
[CC] GO:0097060 |
None
|
CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
2.71335 |
[CC] GO:0045121 |
membrane raft
|
APP, CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.65642 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CNR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, SRC |
2.65534 |
[CC] GO:0098857 |
membrane microdomain
|
APP, CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.64099 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, APP, CA2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC, TEK |
2.2693 |
[CC] GO:0098589 |
membrane region
|
APP, CNR1, EGFR, INSR, KDR, PTGS2, SRC, TEK |
2.19518 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, APEX1, APP, AURKB, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA2, GRIA4, GRIK5, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, MAOB, MIF, MMP2, MMP9, NQO2, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SMAD3, SRC, TOP2A, TYR, XDH |
2.18209 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, TEK |
2.15811 |
[CC] GO:0043197 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.13841 |
[CC] GO:0044309 |
None
|
ADORA1, APP, GRIA2, GRIA4, GRM3 |
2.11037 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, APP, CA2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2, SRC, TEK |
2.0467 |
[CC] GO:0014069 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.0419 |
[CC] GO:0099572 |
None
|
ADORA1, GRIK5, GRM1, GRM3, GRM5, SRC |
2.0419 |
[CC] GO:1903561 |
None
|
AKR1B1, AKR1B10, ALPL, APP, AXL, CA1, CA2, CA4, CA6, CBR1, DUSP3, FABP3, FABP4, GLO1, GRIA4, GRM5, HSPA1A, INSR, MAOB, MIF, MMP9, NQO2, PTGS1, SLC1A1, SRC |
2.02255 |
[CC] GO:0043230 |
None
|
AKR1B1, AKR1B10, ALPL, APP, AXL, CA1, CA2, CA4, CA6, CBR1, DUSP3, FABP3, FABP4, GLO1, GRIA4, GRM5, HSPA1A, INSR, MAOB, MIF, MMP9, NQO2, PTGS1, SLC1A1, SRC |
2.02194 |
[CC] GO:0097458 |
None
|
ADORA1, APP, CA2, CNR1, CNR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, INSR, PTGS1, PTGS2, SRC |
2.00795 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALPL, APEX1, APP, AURKB, AXL, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ESR1, FABP3, FABP4, FLT3, FUT7, GLO1, GRIA4, GRIK5, GRM1, GRM5, HSPA1A, IGF1R, INSR, KDR, MAOB, MIF, MMP12, MMP2, MMP9, NQO2, NUAK1, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TOP2A, TYR, XDH |
2.00144 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.2164 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PIM1, PPARA, PPARD, PTPN1, RORC, SMAD3, TYR, XDH |
14.934 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DUSP3, EGFR, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MIF, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PTGS1, PTGS2, PTPN1, SRC, TEK, TOP2A, TYR, XDH |
11.2437 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EGFR, ESR1, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
10.8664 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.5651 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.445 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, PPARA, PPARD, PTPN1, RORC, SMAD3 |
8.0155 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.96247 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
7.94789 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX5, APEX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSD17B2, MAOB, NQO2, PTGS1, PTGS2, TYR, XDH |
7.21778 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PPARD, RORC, TEK |
7.07907 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
7.07595 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, TOP2A, TYR, XDH |
6.58741 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NQO2, NUAK1, PIK3CA, PIK3CB, PIM1, PPARA, PPARD, SRC, TEK, TOP2A |
6.54513 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.48158 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, TEK |
6.35129 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, GLO1, MMP1, MMP12, MMP2, MMP9, NQO2, NUAK1, PDE5A, PIM1, PPARA, PPARD, PTGS1, PTGS2, PTPN1, RORC, SLC1A1, SMAD3, TOP2A, TYR, XDH |
6.35129 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PPARD, RORC, TEK |
6.17299 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
6.03845 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PPARD, RORC, SMAD3, TEK |
6.02808 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, ESR1, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, PPARA, PPARD, RORC, TEK |
5.93072 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, SRC |
5.79273 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2, TYR |
5.4168 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
5.214 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, CNR1, CNR2, EGFR, FLT3, GPR35, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, IGF1R, INSR, KDR, MET, TEK |
5.214 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.1705 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, FLT3, IGF1R, INSR, KDR, MET, SRC, TEK |
4.92798 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PIK3CA, PIK3CB |
4.80477 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, MAOB, NQO2, PTGS1, PTGS2, SRC, XDH |
4.77301 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
4.64101 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.31473 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIM1, SRC, TEK |
4.1789 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.99741 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARD, SLC1A1, SRC, TEK, TOP2A, XDH |
3.88715 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
3.84548 |
[MF] GO:0042562 |
hormone binding
|
ACHE, EGFR, HSD17B1, IGF1R, INSR, NQO2 |
3.7631 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
3.58979 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.52401 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.32104 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, INSR, KDR |
3.26871 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, MAOB, NQO2, XDH |
3.25269 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
2.99118 |
[MF] GO:0043168 |
anion binding
|
APP, AURKB, AXL, CSNK2A1, EGFR, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, PPARD, SLC1A1, SRC, TEK, TOP2A, XDH |
2.94268 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.86319 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.86319 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK |
2.85512 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2, XDH |
2.7651 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, CSNK2A1, EGFR, ESR1, FLT3, GRIK5, IGF1R, KDR, MAOB, MET, MIF, MMP9, NQO2, PTGS2, SMAD3, TOP2A, TYR, XDH |
2.63332 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH |
2.59806 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, MAOB, MET, NQO2, NUAK1, PDE5A, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A, XDH |
2.59762 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.47654 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.47654 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, PPARA, PPARD, RORC |
2.47326 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, PPARA, PPARD, RORC |
2.47326 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39777 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.39777 |
[MF] GO:0030594 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
2.26497 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.2431 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.2431 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, PPARA, PPARD, RORC |
2.22215 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A |
2.21726 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.12897 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD17B1, HSD17B2 |
2.12328 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A |
2.11394 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, FLT3, HSPA1A, IGF1R, INSR, KDR, MET, NUAK1, PIK3CA, PIK3CB, PIM1, SRC, TEK, TOP2A |
2.08543 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.06475 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.06229 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARD |
2.02334 |
[MF] GO:0052813 |
phosphatidylinositol bisphosphate kinase activity
|
EGFR, MET, PIK3CA, PIK3CB |
2.01161 |